Piero Olliaro

46.5k total citations · 4 hit papers
357 papers, 17.3k citations indexed

About

Piero Olliaro is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Epidemiology. According to data from OpenAlex, Piero Olliaro has authored 357 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 238 papers in Public Health, Environmental and Occupational Health, 71 papers in Parasitology and 68 papers in Epidemiology. Recurrent topics in Piero Olliaro's work include Malaria Research and Control (146 papers), Mosquito-borne diseases and control (86 papers) and Parasites and Host Interactions (62 papers). Piero Olliaro is often cited by papers focused on Malaria Research and Control (146 papers), Mosquito-borne diseases and control (86 papers) and Parasites and Host Interactions (62 papers). Piero Olliaro collaborates with scholars based in Switzerland, United Kingdom and United States. Piero Olliaro's co-authors include Nicholas J. White, Simon L. Croft, Shyam Sundar, Paul Garner, Els Torreele, Walter R. J. Taylor, Michel Vaillant, Philippe J. Guérin, Nathan Ford and Michael O. Harhay and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Piero Olliaro

353 papers receiving 16.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

2002 592 citations Piero Olliaro, Shyam Sundar et al. The Lancet Infectious Diseases profile →
Characterising long COVID: a living systematic review

2021 568 citations Melina Michelen, Lakshmi Manoharan et al. BMJ Global Health profile →
Drug development for neglected diseases: a deficient market and a public-health policy failure

2002 546 citations Piero Olliaro, Els Torreele et al. The Lancet profile →
Scaling up COVID-19 rapid antigen tests: promises and challenges

2021 205 citations Piero Olliaro et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piero Olliaro Switzerland	71	11.0k	3.5k	3.1k	2.9k	1.8k	357	17.3k
Peter G. Kremsner Germany	70	11.4k 1.0×	2.8k 0.8×	4.2k 1.4×	3.4k 1.2×	3.0k 1.7×	629	21.0k
Sanjeev Krishna United Kingdom	63	9.0k 0.8×	2.5k 0.7×	1.9k 0.6×	2.1k 0.7×	4.3k 2.4×	274	16.1k
Arjen M. Dondorp Thailand	69	13.0k 1.2×	2.1k 0.6×	2.4k 0.8×	1.9k 0.7×	2.1k 1.2×	429	17.6k
Philip J. Rosenthal United States	83	14.1k 1.3×	2.9k 0.8×	2.5k 0.8×	3.1k 1.0×	4.8k 2.7×	480	23.2k
Steven R. Meshnick United States	55	5.4k 0.5×	2.0k 0.6×	1.3k 0.4×	2.2k 0.7×	1.6k 0.9×	188	9.5k
François Nosten Thailand	91	24.7k 2.3×	3.5k 1.0×	4.8k 1.6×	3.4k 1.2×	2.6k 1.5×	644	31.8k
Ric N. Price United Kingdom	70	13.4k 1.2×	1.5k 0.4×	2.8k 0.9×	1.6k 0.6×	1.2k 0.7×	328	17.6k
Christopher V. Plowe United States	50	9.1k 0.8×	1.4k 0.4×	1.7k 0.6×	1.5k 0.5×	1.3k 0.7×	169	10.8k
Robert W. Sauerwein Netherlands	77	14.4k 1.3×	2.3k 0.7×	3.2k 1.0×	1.6k 0.6×	3.5k 2.0×	366	19.8k
Nicholas Day United Kingdom	87	15.2k 1.4×	8.3k 2.4×	5.4k 1.8×	10.3k 3.5×	5.6k 3.1×	607	33.6k

Countries citing papers authored by Piero Olliaro

Since Specialization

Citations

This map shows the geographic impact of Piero Olliaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piero Olliaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piero Olliaro more than expected).

Fields of papers citing papers by Piero Olliaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piero Olliaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piero Olliaro. The network helps show where Piero Olliaro may publish in the future.

Co-authorship network of co-authors of Piero Olliaro

This figure shows the co-authorship network connecting the top 25 collaborators of Piero Olliaro. A scholar is included among the top collaborators of Piero Olliaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piero Olliaro. Piero Olliaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García-Gallo, Esteban, Yap Boum, Emmanuel Nakouné, et al.. (2024). Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches. PLoS neglected tropical diseases. 18(6). e0012087–e0012087. 11 indexed citations

Olliaro, Piero, Yap Boum, Emmanuel Nakouné, et al.. (2024). Mpox: The alarm went off. Have we gone back to sleep?. PLoS neglected tropical diseases. 18(1). e0011871–e0011871. 1 indexed citations

Kiemdé, François, Sabine Dittrich, Piero Olliaro, et al.. (2024). Impact of a package of point-of-care diagnostic tests, a clinical diagnostic algorithm and adherence training on antibiotic prescriptions for the management of non-severe acute febrile illness in primary health facilities during the COVID-19 pandemic in Burkina Faso. BMC Infectious Diseases. 24(1). 870–870. 1 indexed citations

Gonofio, Ella, Benjamin Sélekon, Alexandre Manirakiza, et al.. (2023). Laboratory Diagnosis of Mpox, Central African Republic, 2016–2022. Emerging infectious diseases. 29(9). 1846–1849. 2 indexed citations

Farlow, Andrew, Els Torreele, Glenda Gray, et al.. (2023). The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Vaccines. 11(3). 690–690. 29 indexed citations

Jones, Benjamin, et al.. (2023). Variability in clinical assessment of clade IIb mpox lesions. International Journal of Infectious Diseases. 137. 60–62. 6 indexed citations

Torreele, Els, et al.. (2023). Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?. The Lancet Infectious Diseases. 23(7). e253–e258. 14 indexed citations

Kukula, Vida, Clement T. Narh, Piero Olliaro, et al.. (2023). Impact of Point-of-Care Rapid Diagnostic Tests on Antibiotic Prescription Among Patients Aged <18 Years in Primary Healthcare Settings in 2 Peri-Urban Districts in Ghana: Randomized Controlled Trial Results. Clinical Infectious Diseases. 77(Supplement_2). S145–S155. 7 indexed citations

Baruch, Joaquín, Amanda Rojek, Christiana Kartsonaki, et al.. (2022). Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients. Influenza and Other Respiratory Viruses. 16(6). 1040–1050. 6 indexed citations

10.

Olliaro, Piero, Els Torreele, & Michel Vaillant. (2021). COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. The Lancet Microbe. 2(7). e279–e280. 132 indexed citations

11.

Michelen, Melina, Lakshmi Manoharan, Natalie Elkheir, et al.. (2021). Characterising long COVID: a living systematic review. BMJ Global Health. 6(9). e005427–e005427. 568 indexed citations breakdown →

12.

Andrianaivoarimanana, Voahangy, Minoarisoa Rajerison, Mihaja Raberahona, et al.. (2021). The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague. PLoS neglected tropical diseases. 15(12). e0010064–e0010064. 4 indexed citations

13.

Boukthir, Aïcha, Jihène Bettaieb, Astrid C. Erber, et al.. (2020). Psycho-social impacts, experiences and perspectives of patients with Cutaneous Leishmaniasis regarding treatment options and case management: An exploratory qualitative study in Tunisia. PLoS ONE. 15(12). e0242494–e0242494. 22 indexed citations

14.

Hussain‐Alkhateeb, Laith, Axel Kroeger, Piero Olliaro, et al.. (2018). Early warning and response system (EWARS) for dengue outbreaks: Recent advancements towards widespread applications in critical settings. PLoS ONE. 13(5). e0196811–e0196811. 44 indexed citations

15.

Harhay, Michael O., et al.. (2011). Polyparasitism - A systematic review of gastro-intestinal co-infections with soil-transmitted nematodes (STN). Tropical Medicine & International Health. 16. 176–176. 1 indexed citations

16.

Sundar, Shyam, Prabhat Kumar Sinha, Madhukar Rai, et al.. (2011). Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet. 377(9764). 477–486. 239 indexed citations

17.

Terlouw, Dianne J., et al.. (2008). Regional Age-Based Dose Regimens for a New Fixed-Dose Combination of Artesunate-Mefloquine for the Treatment of Uncomplicated Falciparum Malaria in Latin America and Asia. American Journal of Tropical Medicine and Hygiene. 79. 216–216. 2 indexed citations

18.

Brasseur, Philippe, Patrice Agnamey, Oumar Gaye, et al.. (2007). Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal. Malaria Journal. 6(1). 150–150. 31 indexed citations

19.

Olliaro, Piero & Yongyuth Yuthavong. (1999). An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery. Pharmacology & Therapeutics. 81(2). 91–110. 123 indexed citations

20.

Olliaro, Piero & P. I. Trigg. (1995). Le point sur les antipaludiques en cours de développement. Bulletin of the World Health Organization. 73(6). 741–747. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact